About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effect of Ondansetron for Withdrawal Symptoms | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00695864

Effect of Ondansetron for Withdrawal Symptoms

We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has...

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Stanford University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•No medical contraindications to medication

Exclusion Criteria

•Subjects will be excluded if they have a history of significant psychiatric disorders that would prevent them from engaging in a treatment program.
•Participating in other studies that would interfere with the procedures in this study
•Known or apparent pregnancy

Related studies

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

NCT00792415 · Substance Withdrawal Syndrome

Opioid Withdrawal Symptoms in Critically Ill Patients

NCT03374722 · Substance Withdrawal Syndrome, Critical Illness

COMPLETEDPhase 1

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

NCT02801357 · Substance Withdrawal Syndrome, Opiate Addiction, and more

COMPLETEDPhase 2/3

Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal

NCT00980044 · Substance Withdrawal Syndrome

COMPLETEDPhase 1

Acute Withdrawal From Smoked Cocaine - 9

NCT00000292 · Cocaine-Related Disorders, Substance Withdrawal Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 15, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment31

Start dateMay 2008

Last updatedMay 15, 2017

Condition

Substance Withdrawal Syndrome

Locations shown

Stanford University School of Medicine

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions